Zipalertinib is an investigational, oral, EGFR tyrosine kinase inhibitor designed to selectively inhibit EGFR variants with ex20ins mutations.

In this study, researchers surveyed nurses at the Turkish Palestinian Friendship Hospital in Gaza about safe ...

A qualitative study evaluated the information-seeking behaviors of patients undergoing genetic testing for hereditary breast cancer.

Angelica” is the name assigned to an AI program deployed last year by Kern Family Health Care, the largest provider of ...

In this analysis, researchers analyzed patient-level estimates of cancer-attributable costs based on clinical and ...

In this study, researchers evaluated the germline variants of patients receiving CAR T-cell therapy to screen for the effects of mutations on CAR T-cell behavior in humans.

Researchers evaluated a low-dose chemotherapy induction regimen compared with standard-dose therapy in pediatric patients with AML.

Investigators assessed whether acalabrutinib could overcome age-related toxicity limitations that prevented successful combination of ibrutinib with R-CHOP in previously untreated patients with DLBCL.

Accelerated approval is based on objective response rate and duration of response from the phase 2 IGNYTE trial in anti-PD-1-pretreated advanced melanoma.

Taylor Fresh Foods of Salinas, California, announced the voluntary recall Sunday after learning that its pepper supplier was recalling fresh jalapeños tied to a multistate outbreak, according to a ...

The latest systematic review on kidney tumor enucleation vs partial nephrectomy includes contemporary robot-assisted series and randomized studies.

A contemporary systematic review and meta-analysis of 103 mostly retrospective studies characterized the efficacy and safety of renal tumor biopsy.